168 related articles for article (PubMed ID: 24688106)
21. Transformation in follicular lymphoma: biology, prognosis, and therapeutic options.
Wong E; Dickinson M
Curr Oncol Rep; 2012 Oct; 14(5):424-32. PubMed ID: 22865028
[TBL] [Abstract][Full Text] [Related]
22. Use of Smooth Muscle Myosin Heavy Chain as an Effective Marker of Follicular Dendritic Cells.
Ioannidis I; Laurini JA
Appl Immunohistochem Mol Morphol; 2019 Jan; 27(1):48-53. PubMed ID: 28549038
[TBL] [Abstract][Full Text] [Related]
23. The composition of the microenvironment in follicular lymphoma is associated with the stage of the disease.
Koch K; Hoster E; Unterhalt M; Ott G; Rosenwald A; Hansmann ML; Engelhard M; Hiddemann W; Klapper W
Hum Pathol; 2012 Dec; 43(12):2274-81. PubMed ID: 22795355
[TBL] [Abstract][Full Text] [Related]
24. Automated prognostic pattern detection shows favourable diffuse pattern of FOXP3(+) Tregs in follicular lymphoma.
Nelson LS; Mansfield JR; Lloyd R; Oguejiofor K; Salih Z; Menasce LP; Linton KM; Rose CJ; Byers RJ
Br J Cancer; 2015 Oct; 113(8):1197-205. PubMed ID: 26439683
[TBL] [Abstract][Full Text] [Related]
25. Composite follicular lymphoma and nodular lymphocyte predominance Hodgkin's disease.
Dargent JL; Lespagnard L; Meiers I; Bradstreet C; Heimann P; De Wolf-Peeters C
Virchows Arch; 2005 Oct; 447(4):778-80. PubMed ID: 15983819
[No Abstract] [Full Text] [Related]
26. Transformation of follicular lymphoma - Why does it happen and can it be prevented?
Link BK
Best Pract Res Clin Haematol; 2018 Mar; 31(1):49-56. PubMed ID: 29452666
[TBL] [Abstract][Full Text] [Related]
27. The tumor microenvironment in follicular lymphoma.
Yang ZZ; Ansell SM
Clin Adv Hematol Oncol; 2012 Dec; 10(12):810-8. PubMed ID: 23271353
[TBL] [Abstract][Full Text] [Related]
28. miR-31 and miR-17-5p levels change during transformation of follicular lymphoma.
Thompson MA; Edmonds MD; Liang S; McClintock-Treep S; Wang X; Li S; Eischen CM
Hum Pathol; 2016 Apr; 50():118-26. PubMed ID: 26997445
[TBL] [Abstract][Full Text] [Related]
29. Fine needle aspiration cytology of histiocytic sarcoma with dendritic cell differentiation: a case of transdifferentiation from low-grade follicular lymphoma.
Mehrotra S; Pan Z
Diagn Cytopathol; 2015 Aug; 43(8):659-63. PubMed ID: 25993973
[TBL] [Abstract][Full Text] [Related]
30. Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.
Richendollar BG; Pohlman B; Elson P; Hsi ED
Hum Pathol; 2011 Apr; 42(4):552-7. PubMed ID: 21237493
[TBL] [Abstract][Full Text] [Related]
31. Follicular large-cell lymphoma of the orbit: a clinicopathologic, immunohistochemical and molecular genetic description of one case.
Nicolò M; Truini M; Sertoli M; Taubenberger JK; Zingirian M
Graefes Arch Clin Exp Ophthalmol; 1999 Jul; 237(7):606-10. PubMed ID: 10424312
[TBL] [Abstract][Full Text] [Related]
32. Pathogenesis of follicular lymphoma.
Lackraj T; Goswami R; Kridel R
Best Pract Res Clin Haematol; 2018 Mar; 31(1):2-14. PubMed ID: 29452662
[TBL] [Abstract][Full Text] [Related]
33. The number of lymphoma-associated macrophages in tumor tissue is an independent prognostic factor in patients with follicular lymphoma.
Andjelic B; Mihaljevic B; Todorovic M; Bila J; Jakovic L; Jovanovic MP
Appl Immunohistochem Mol Morphol; 2012 Jan; 20(1):41-6. PubMed ID: 21768878
[TBL] [Abstract][Full Text] [Related]
34. Dissecting follicular lymphoma: high versus low risk.
Smith SM
Hematology Am Soc Hematol Educ Program; 2013; 2013():561-7. PubMed ID: 24319232
[TBL] [Abstract][Full Text] [Related]
35. SIRPα expression delineates subsets of intratumoral monocyte/macrophages with different functional and prognostic impact in follicular lymphoma.
Chen YP; Kim HJ; Wu H; Price-Troska T; Villasboas JC; Jalali S; Feldman AL; Novak AJ; Yang ZZ; Ansell SM
Blood Cancer J; 2019 Oct; 9(10):84. PubMed ID: 31611550
[TBL] [Abstract][Full Text] [Related]
36. Bilateral conjunctival follicular lymphoma in a child.
Wall PB; Traboulsi EI; Hsi ED; Singh AD
J AAPOS; 2015 Apr; 19(2):183-5. PubMed ID: 25824110
[TBL] [Abstract][Full Text] [Related]
37. Peripheral T-cell lymphoma with follicular involvement and a CD4+/bcl-6+ phenotype.
de Leval L; Savilo E; Longtine J; Ferry JA; Harris NL
Am J Surg Pathol; 2001 Mar; 25(3):395-400. PubMed ID: 11224611
[TBL] [Abstract][Full Text] [Related]
38. Glycolytic biomarkers predict transformation in patients with follicular lymphoma.
Monrad I; Madsen C; Lauridsen KL; Honoré B; Plesner TL; Hamilton-Dutoit S; d'Amore F; Ludvigsen M
PLoS One; 2020; 15(5):e0233449. PubMed ID: 32442224
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of tryptophan catabolism in follicular lymphoma.
Masaki A; Ishida T; Maeda Y; Ito A; Suzuki S; Narita T; Kinoshita S; Yoshida T; Ri M; Kusumoto S; Komatsu H; Inagaki H; Ueda R; Choi I; Suehiro Y; Iida S
Hematol Oncol; 2020 Dec; 38(5):742-753. PubMed ID: 32940915
[TBL] [Abstract][Full Text] [Related]
40. Rituximab treatment circumvents the prognostic impact of tumor-infiltrating T-cells in follicular lymphoma patients.
Xerri L; Huet S; Venstrom JM; Szafer-Glusman E; Fabiani B; Canioni D; Chassagne-Clément C; Dartigues-Cuilléres P; Charlotte F; Laurent C; Gelas-Dore B; Bolen CR; Punnoose E; Bouabdallah R; Brice P; Morschhauser F; Cartron G; Olive D; Salles G;
Hum Pathol; 2017 Jun; 64():128-136. PubMed ID: 28414090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
